3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Pancreatic Neoplasms
2
Obesity
2
Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Treatment Adherence and Compliance
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoking
1
Sarcoma
1
Risk Reduction Behavior
1
Rectal Neoplasms
1
Radiation Injuries
1
Pulmonary Disease, Chronic Obstructive
1
Prosthesis-Related Infections
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Overweight
1
Osteosarcoma
1
Orgasm
1
Obesity, Morbid
1
Noncommunicable Diseases
1
Neuroendocrine Tumors
1
Interventions
Alginates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
OTHER_GOV
×
Esophagitis
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled